Zhejiang Haichang Biotech Co., Ltd.

This study tests a new drug called WGI-0301 combined with the immunotherapy nivolumab in people with advanced liver or kidney cancer. The goal is to see if the combination is safe, how the body handles it, and whether it can shrink tumors. About 230 adults aged 18-75 will take pa…

This study tests a new drug, WGI-0301, combined with lenvatinib in 80 adults with advanced liver cancer that hasn't responded to first treatment. The goal is to see if the combination can shrink tumors and is safe. Participants will receive both drugs and be monitored for side ef…